Request Deal Involvement
Intas Pharmaceuticals completed the acquisition of Udenyca from Coherus for $558m.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
financial advisors
JP Morgan
legal advisors
Latham & Watkins
pr advisors
Argot Partners
legal advisors
Smith Anderson
or
Principals
target
UDENYCA
vendor
COHERUS BIOSCIENCES
bidder
INTAS PHARMACEUTICALS
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite